Volume 18, Issue 3 (11-2004)                   Med J Islam Repub Iran 2004 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
SOLElMANI M, MOZDARANI H, POURFATHOLLAH A, MORTAZAVI Y, ALIMOGHADDAM K, HAJIFATHALI A et al . EXPANSION OF HUMAN CORD BLOOD PRIMITIVE PROGENITORS IN SERUM-FREE MEDIA USING HUMAN BONE MARROW MESENCHYMAL STEM CELLS. Med J Islam Repub Iran 2004; 18 (3) :257-263
URL: http://mjiri.iums.ac.ir/article-1-599-en.html
EXPANSION OF HUMAN CORD BLOOD PRIMITIVE PROGENITORS IN SERUM-FREE MEDIA USING HUMAN BONE MARROW MESENCHYMAL STEM CELLS
M SOLElMANI , H MOZDARANI , AA POURFATHOLLAH , Y MORTAZAVI , K ALIMOGHADDAM , A HAJIFATHALI , Z ZONOBI
Medical Genetics Dept. School of Medical Sciences, Tarbiat Modares University, Tehran , mozdaranh@modares.ac.ir
Abstract:   (4856 Views)
Ex vivo expansion of human umbilical cord blood cells (HUCBC) is explored by several investigators to enhance the repopulating potential of HUCBC. The proliferation and expansion of human hematopoietic stem cells (HSC) in ex vivo culture was examined with the goal of generating a suitable clinical protocol for expanding HSC for patient transplantation. Using primary human mesenchymal stem cells, we established a serum-free culture system to expand human primitive progenitors and transplantable stem cells. Non-enriched cord blood CD34+ cells were cultured on a monolayer of human mesenchymal stem cells in the presence of tlu-ombopoietin (TPO), flt31flk2 ligand (FL), and/or stem cell factor (SCF), interleukin 6 (IL-6), interleukin 3 (IL-3) under serum-free conditions. After I or 2 weeks of culture, cells were examined for clonogenic progenitors and percentage of CD34+ CD38- cells. In the presence of TPO, FL, and SCF, fetal MSC cells supported more than a 35- and 20-fold expansion of CD34+ cells and colonyforming units in culture after 1 and 2 weeks of incubation, respectively. In addition, LTC-IC assay were expanded more than 7- and 16-fold after 1 and 2 weeks of culture, respectively. UCB-HSC can be expanded in culture to numbers theoretically adequate for safe, rapid engraftment of adult patients. Additional studies are needed to establish the functional activity of expanded UCB-HSC. This ex vivo expansion system should prove valuable in clinical settings in which stromal cells are available from recipients or stem cell donors.
Keywords: Ex vivo expansion; Stem cells; Umbilical cord blood; Mesenchymal stem cells.
Full-Text [PDF 240 kb]   (1577 Downloads)    
Type of Study: Original Research: Basic Science in Medicine |
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.